Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 2941 AL 2955

Ocular motor abnormalities in Parkinsonian syndromes

Pinkhardt EH, Kassubek J.

Parkinsonism Relat Disord. 2011 May;17(4):223-30. doi: 10.1016/j.parkreldis.2010.08.004. Epub 2010 Aug 30.

Assessing mobility at home in people with early Parkinson's disease using an instrumented Timed Up and Go test

Zampieri C, Salarian A, Carlson-Kuhta P, Nutt JG, Horak FB.

Parkinsonism Relat Disord. 2011 May;17(4):277-80. doi: 10.1016/j.parkreldis.2010.08.001. Epub 2010 Aug 30.

Brain iron metabolism and its perturbation in neurological diseases

Crichton RR, Dexter DT, Ward RJ.

J Neural Transm (Vienna). 2011 Mar;118(3):301-14. doi: 10.1007/s00702-010-0470-z. Epub 2010 Sep 1.

Nitrosylation and nitration of mitochondrial complex I in Parkinson's disease

Chinta SJ, Andersen JK.

Free Radic Res. 2011 Jan;45(1):53-8. doi: 10.3109/10715762.2010.509398. Epub 2010 Sep 6.

Laserlight cues for gait freezing in Parkinson's disease: an open-label study

Donovan S, Lim C, Diaz N, Browner N, Rose P, Sudarsky LR, Tarsy D, Fahn S, Simon DK.

Parkinsonism Relat Disord. 2011 May;17(4):240-5. doi: 10.1016/j.parkreldis.2010.08.010. Epub 2010 Sep 3.

The use of subcutaneous scopolamine as a palliative treatment in Parkinson's disease

Pérez LM, Farriols C, Puente V, Planas J, Ruiz I.

Palliat Med. 2011 Jan;25(1):92-3. doi: 10.1177/0269216310381662. Epub 2010 Sep 3.

The dominant-STN phenomenon in bilateral STN DBS for Parkinson's disease

Castrioto A, Meaney C, Hamani C, Mazzella F, Poon YY, Lozano AM, Hodaie M, Moro E.

Neurobiol Dis. 2011 Jan;41(1):131-7. doi: 10.1016/j.nbd.2010.08.029. Epub 2010 Sep 6.

Pathological considerations in the treatment of Parkinson's disease: more than just a wiring diagram

Hurelbrink CB, Lewis SJ.

Clin Neurol Neurosurg. 2011 Jan;113(1):1-6. doi: 10.1016/j.clineuro.2010.08.010. Epub 2010 Sep 9.

Gastrointestinal dysfunction in Parkinson's disease

Pfeiffer RF.

Parkinsonism Relat Disord. 2011 Jan;17(1):10-5. doi: 10.1016/j.parkreldis.2010.08.003. Epub 2010 Sep 15.

Hyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease

Berg D.

J Neural Transm (Vienna). 2011 Mar;118(3):453-61. doi: 10.1007/s00702-010-0469-5. Epub 2010 Sep 10.

Determinants of health-related quality of life in Parkinson's disease: a systematic review

Soh SE, Morris ME, McGinley JL.

Parkinsonism Relat Disord. 2011 Jan;17(1):1-9. doi: 10.1016/j.parkreldis.2010.08.012. Epub 2010 Sep 15.

Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome

Rohrer JD, Paviour D, Vandrovcova J, Hodges J, de Silva R, Rossor MN.

Neurodegener Dis. 2011;8(3):149-52. doi: 10.1159/000319454. Epub 2010 Sep 14.

Effect of controlled-release levodopa on the microstructure of sleep in Parkinson's disease

Wailke S, Herzog J, Witt K, Deuschl G, Volkmann J.

Eur J Neurol. 2011 Apr;18(4):590-6. doi: 10.1111/j.1468-1331.2010.03213.x. Epub 2010 Sep 17.

Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in rats

Riddle LR, Kumar R, Griffin SA, Grundt P, Newman AH, Luedtke RR.

Neuropharmacology. 2011 Feb-Mar;60(2-3):284-94. doi: 10.1016/j.neuropharm.2010.09.011. Epub 2010 Sep 17.

Multi-organ autonomic dysfunction in Parkinson disease

Jain S.

Parkinsonism Relat Disord. 2011 Feb;17(2):77-83. doi: 10.1016/j.parkreldis.2010.08.022. Epub 2010 Sep 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias